Literature DB >> 25722650

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Lise J Estcourt1, Richard Gregg2, Simon Stanworth1, Carolyn Doree3, Marialena Trivella4, Michael F Murphy5, Alan Tinmouth6.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To determine whether alternative agents (e.g. artificial platelet substitutes, platelet-poor plasma, fibrinogen, rFVIIa, thrombopoietin mimetics) are as effective and safe as the use of platelet transfusions for the prevention of bleeding (prophylactic platelet transfusion) in patients with haematological disorders who are undergoing myelosuppressive chemotherapy or stem cell transplantation. Antifibrinolytics (lysine analogues) will not be included in this review because they have been the focus of another Cochrane review (Wardrop 2013).

Entities:  

Year:  2014        PMID： 25722650      PMCID： PMC4338548          DOI： 10.1002/14651858.CD010982

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


  63 in total

1.  Hematopoietic stem cell transplantation: a global perspective.

Authors:  Alois Gratwohl; Helen Baldomero; Mahmoud Aljurf; Marcelo C Pasquini; Luis Fernando Bouzas; Ayami Yoshimi; Jeff Szer; Jeff Lipton; Alvin Schwendener; Michael Gratwohl; Karl Frauendorfer; Dietger Niederwieser; Mary Horowitz; Yoshihisa Kodera
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

Review 2.  Platelet transfusions for patients with haematological malignancies: who needs them?

Authors:  Lise J Estcourt; S J Stanworth; M F Murphy
Journal:  Br J Haematol       Date:  2011-05-25       Impact factor: 6.998

3.  The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study.

Authors:  D J Higby; E Cohen; J F Holland; L Sinks
Journal:  Transfusion       Date:  1974 Sep-Oct       Impact factor: 3.157

Review 4.  Controversies in platelet transfusion therapy.

Authors:  S J Slichter
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

Review 5.  Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.

Authors:  Ewurabena Simpson; Yulia Lin; Simon Stanworth; Janet Birchall; Carolyn Doree; Chris Hyde
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

6.  [Clinical study on platelet engraftment by thrombopoietin in patients with hematological malignancies after allogeneic hematopoietic stem cell transplantation].

Authors:  Miao Miao; De-pei Wu; Xiang-shan Cao; Wei-min Dong; Biao Wang; Yang-jian Ou; Zhen-yu Li; De-peng Li; Ming-zhen Yang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2012-05

Review 7.  The role of fibrinogen: a new paradigm in the treatment of coagulopathic bleeding.

Authors:  Benny Sørensen; Mariann Tang; Ole H Larsen; Peter N Laursen; Christian Fenger-Eriksen; Catherine J Rea
Journal:  Thromb Res       Date:  2011       Impact factor: 3.944

8.  Novel platelet substitutes: disk-shaped biodegradable nanosheets and their enhanced effects on platelet aggregation.

Authors:  Yosuke Okamura; Yoshihito Fukui; Koki Kabata; Hidenori Suzuki; Makoto Handa; Yasuo Ikeda; Shinji Takeoka
Journal:  Bioconjug Chem       Date:  2009-09-29       Impact factor: 4.774

9.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279

10.  Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001.

Authors:  M P Coleman; B Rachet; L M Woods; E Mitry; M Riga; N Cooper; M J Quinn; H Brenner; J Estève
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640
View more
  5 in total

1.  Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review.

Authors:  Michael Desborough; Lise J Estcourt; Anna Chaimani; Carolyn Doree; Sally Hopewell; Marialena Trivella; Andreas V Hadjinicolaou; Paresh Vyas; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2016-01-26

Review 2.  Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon J Stanworth; Carolyn Doree; Sally Hopewell; Marialena Trivella; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2015-11-18

Review 3.  A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Gemma L Crighton; Lise J Estcourt; Erica M Wood; Marialena Trivella; Carolyn Doree; Simon Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2015-09-30

Review 4.  Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.

Authors:  Michael Desborough; Lise J Estcourt; Carolyn Doree; Marialena Trivella; Sally Hopewell; Simon J Stanworth; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2016-08-22

Review 5.  Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Patricia Blanco; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2015-10-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.